Phathom Pharmaceuticals Statistics

Total Valuation

PHAT has a market cap or net worth of $275.56 million. The enterprise value is $532.56 million.

Market Cap	275.56M
Enterprise Value	532.56M

Important Dates

The next confirmed earnings date is Thursday, May 1, 2025, before market open.

Earnings Date	May 1, 2025
Ex-Dividend Date	n/a

Share Statistics

PHAT has 68.38 million shares outstanding. The number of shares has increased by 23.18% in one year.

Current Share Class	68.38M
Shares Outstanding	68.38M
Shares Change (YoY)	+23.18%
Shares Change (QoQ)	+9.93%
Owned by Insiders (%)	3.86%
Owned by Institutions (%)	70.58%
Float	55.61M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.60
Forward PS	1.61
PB Ratio	-1.08
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	9.64
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.20

Current Ratio	4.20
Quick Ratio	3.92
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-3.85

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-43.78%
Return on Invested Capital (ROIC)	-51.42%
Return on Capital Employed (ROCE)	-94.83%
Revenue Per Employee	$129,396
Profits Per Employee	-$782,965
Employee Count	427
Asset Turnover	0.14
Inventory Turnover	3.61

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -55.27% in the last 52 weeks. The beta is 0.35, so PHAT's price volatility has been lower than the market average.

Beta (5Y)	0.35
52-Week Price Change	-55.27%
50-Day Moving Average	5.28
200-Day Moving Average	10.41
Relative Strength Index (RSI)	38.75
Average Volume (20 Days)	1,251,163

Short Selling Information

The latest short interest is 12.91 million, so 18.88% of the outstanding shares have been sold short.

Short Interest	12.91M
Short Previous Month	14.36M
Short % of Shares Out	18.88%
Short % of Float	23.22%
Short Ratio (days to cover)	9.48

Income Statement

In the last 12 months, PHAT had revenue of $55.25 million and -$334.33 million in losses. Loss per share was -$5.29.

Revenue	55.25M
Gross Profit	47.28M
Operating Income	-277.47M
Pretax Income	-297.11M
Net Income	-334.33M
EBITDA	-276.67M
EBIT	-277.47M
Loss Per Share	-$5.29

Full Income Statement

Balance Sheet

The company has $297.26 million in cash and $554.95 million in debt, giving a net cash position of -$257.69 million or -$3.77 per share.

Cash & Cash Equivalents	297.26M
Total Debt	554.95M
Net Cash	-257.69M
Net Cash Per Share	-$3.77
Equity (Book Value)	-253.58M
Book Value Per Share	-3.70
Working Capital	274.41M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$266.77 million and capital expenditures -$135,000, giving a free cash flow of -$266.91 million.

Operating Cash Flow	-266.77M
Capital Expenditures	-135,000
Free Cash Flow	-266.91M
FCF Per Share	-$3.90

Full Cash Flow Statement

Margins

Gross Margin	85.57%
Operating Margin	-502.18%
Pretax Margin	-605.09%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

PHAT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-23.18%
Shareholder Yield	-23.18%
Earnings Yield	-121.63%
FCF Yield	-97.10%

Analyst Forecast

The average price target for PHAT is $22.50, which is 458.31% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$22.50
Price Target Difference	458.31%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	78.22%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

PHAT has an Altman Z-Score of -5.4 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-5.4
Piotroski F-Score	3